Interestingly, serum levels of IL-17 in AD patients have been shown to be elevated [270, 271], and similar observations of infiltrating TH17 cells into the brain and increased levels of IL-17 in the CSF and blood have been reported in MS patients [272–274]. This evidence concerns the gene IL17A and myeloid sarcoma.